Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I)
Ann Int Med 117:933-946, Gessain,A.&Gout,O., 1992
HTLV-I-Associated Myelopathy Associated with Blood Transfusion in the US:Epidemiologic & Molecular Evidence
Neurol 41:192-197, Kaplan,J.E.,et al, 1991
HTLV-I-Associated Myelopathy:Clinicopathologic Correlation with Localization of Provirus to Spinal Cord
Neurol 41:1990-1992, Bhigjee,A.I.,et al, 1991
Rapid Development of Myelopathy after HTLV-1 Infection Acquired by Transfusion During Cardiac Transplantation
NEJM 322:383-387, Gout,O.,et al, 1990
HTLV-I-Associated Myelopathy
NEJM 323:552, Engel,W.K.,et al, 1990
Nationwide Survey of HTLV-I-Associated Myelopathy in Japan:Ass with Blood Transufsion
Ann Neurol 28:50-56, Osame,M.,et al, 1990
Detection of Human T-Cell Leukemia/Lymphoma Virus Type I in a Transfusion Recipient with Chronic Myelopathy
Neurol 39:841-844, Saxton,E.H.,et al, 1989
Fat Embolism Syndrome in Sickle Cell Disease
J Clin Med 9:1-12, Tsitsikas, D.A.,et al, 2020
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014
West Nile Virus Encephalitis
NEJM 347:1225-1226, Peterson,L.R.,et al, 2002
Discontinuation of Long-Term Transfusion Therapy in Patients with Sickle Cell Disease & Stroke
J Pediatr 131:757-760, Rana,S.,et al, 1997
Risk of Recurrent Stroke in Patients with Sickle Cell Disease Treated with Erythrocyte Transfusions
J Pediatr 126:896-899, Pegelow,C.H.,et al, 1995
High Risk of Recurrent Stroke after Discont of 5 to 12 Yrs of Transfusions in Sickle Cell Disease
J Pediatr 118:377-379, Wang,W.C.,et al, 1991